Plato Investment Management LTD Bristol Myers Squibb CO Transaction History
Plato Investment Management LTD
- $1.23 Trillion
- Q3 2024
A detailed history of Plato Investment Management LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Plato Investment Management LTD holds 117,401 shares of BMY stock, worth $6.58 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
117,401
Previous 103,954
12.94%
Holding current value
$6.58 Million
Previous $4.32 Billion
40.56%
% of portfolio
0.49%
Previous 0.4%
Shares
4 transactions
Others Institutions Holding BMY
# of Institutions
2,536Shares Held
1.47BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$10.6 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.89 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.21 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.37 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.42 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...